“NATION-WIDE SURVEY ON THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CURRENT CLINICAL PRACTICE IN ITALY” (2023) Mediterranean Journal of Hematology and Infectious Diseases, 15(1), p. e2023019. doi:10.4084/MJHID.2023.019.